Cyclopentane

Cyclopentane

SCHEMBL27697390

C1CCCC1.CCCCC(N)=O.NC=O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.50
SOAT1 P35610 2/20 0.50
TP53 P04637 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C19 P33261 1/20 0.50
CNR1 P21554 1/20 0.47
KDM4E B2RXH2 2/20 0.46
CES1 P23141 3/20 0.44
CES2 O00748 2/20 0.44
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA1 P00915 1/20 0.39
TRPA1 O75762 1/20 0.36
AKR1B1 P15121 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane SCHEMBL9985763 0.91 CES1 (0.52) FAAHSOAT1TP53MEN1KMT2A
Formamide SCHEMBL4240947 0.86 FAAH (0.65) FAAHSOAT1TP53MEN1KMT2A
Formamide SCHEMBL9804248 0.84 SOAT1 (0.69) FAAHSOAT1TP53MEN1KMT2A
SCHEMBL20284 0.83
SCHEMBL28855277 0.83 CES1 (0.61) FAAHSOAT1TP53MEN1KMT2A
Palmitamide SCHEMBL3984610 0.81 SOAT1 (0.65) FAAHSOAT1TP53MEN1KMT2A
Cyclohexane SCHEMBL3839638 0.81 SOAT1 (0.65) FAAHSOAT1TP53MEN1KMT2A
Cyclohexane SCHEMBL22283339 0.81 SOAT1 (0.65) FAAHSOAT1TP53MEN1KMT2A
Cyclohexane SCHEMBL3840067 0.81 SOAT1 (0.65) FAAHSOAT1TP53MEN1KMT2A
Cyclohexane SCHEMBL2898947 0.81 SOAT1 (0.65) FAAHSOAT1TP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101155803-A Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate INKE SA (ES) 2008-04-02 CN claimed
CN-101155803-A Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate INKE SA (ES) 2008-04-02 CN disclosed